aluates Reports

$ 0.0

Automative

Global Diabetic Peripheral Neuropathy Treatment Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-20U6107

Global Diabetic Peripheral Neuropathy Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Diabetic Peripheral Neuropathy Treatment Market Research Report 2024

Code: QYRE-Auto-20U6107

Report

August 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Achelios Therapeutics Inc

Celgene Corp

Commence Bio Inc

Grunenthal

Immune Pharmaceuticals Inc

KPI Therapeutics Inc

Medifron DBT Co Ltd

Mitsubishi Tanabe Pharma Corp

Novaremed

Reata Pharmaceuticals Inc

Relief Therapeutics Holding AG

ViroMed

Diabetic Peripheral Neuropathy Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Diabetic Peripheral Neuropathy Treatment Market

The global Diabetic Peripheral Neuropathy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diabetic Peripheral Neuropathy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Peripheral Neuropathy Treatment.

Report Scope

The Diabetic Peripheral Neuropathy Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Peripheral Neuropathy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Peripheral Neuropathy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diabetic Peripheral Neuropathy Treatment Market Report

Report Metric	Details
Report Name	Diabetic Peripheral Neuropathy Treatment Market
CAGR	5%
Segment by Type	Antimunocel ASP-8477 BNV-222 Capsaicin CBX-129801 Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Achelios Therapeutics Inc, Celgene Corp, Commence Bio Inc, Grunenthal GmbH, Immune Pharmaceuticals Inc, KPI Therapeutics Inc, Medifron DBT Co Ltd, Mitsubishi Tanabe Pharma Corp, Novaremed Ltd, Reata Pharmaceuticals Inc, Relief Therapeutics Holding AG, ViroMed Co Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Peripheral Neuropathy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diabetic Peripheral Neuropathy Treatment Market report?

Ans: The main players in the Diabetic Peripheral Neuropathy Treatment Market are Achelios Therapeutics Inc, Celgene Corp, Commence Bio Inc, Grunenthal GmbH, Immune Pharmaceuticals Inc, KPI Therapeutics Inc, Medifron DBT Co Ltd, Mitsubishi Tanabe Pharma Corp, Novaremed Ltd, Reata Pharmaceuticals Inc, Relief Therapeutics Holding AG, ViroMed Co Ltd

What are the Application segmentation covered in the Diabetic Peripheral Neuropathy Treatment Market report?

Ans: The Applications covered in the Diabetic Peripheral Neuropathy Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Diabetic Peripheral Neuropathy Treatment Market report?

Ans: The Types covered in the Diabetic Peripheral Neuropathy Treatment Market report are Antimunocel, ASP-8477, BNV-222, Capsaicin, CBX-129801, Others

Recommended Reports

Diabetes Care Markets

Pain Management Solutions

Neurological Disorder Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antimunocel

1.2.3 ASP-8477

1.2.4 BNV-222

1.2.5 Capsaicin

1.2.6 CBX-129801

1.2.7 Others

1.3 Market by Application

1.3.1 Global Diabetic Peripheral Neuropathy Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Peripheral Neuropathy Treatment Market Perspective (2019-2030)

2.2 Diabetic Peripheral Neuropathy Treatment Growth Trends by Region

2.2.1 Global Diabetic Peripheral Neuropathy Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetic Peripheral Neuropathy Treatment Historic Market Size by Region (2019-2024)

2.2.3 Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Region (2025-2030)

2.3 Diabetic Peripheral Neuropathy Treatment Market Dynamics

2.3.1 Diabetic Peripheral Neuropathy Treatment Industry Trends

2.3.2 Diabetic Peripheral Neuropathy Treatment Market Drivers

2.3.3 Diabetic Peripheral Neuropathy Treatment Market Challenges

2.3.4 Diabetic Peripheral Neuropathy Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetic Peripheral Neuropathy Treatment Players by Revenue

3.1.1 Global Top Diabetic Peripheral Neuropathy Treatment Players by Revenue (2019-2024)

3.1.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Diabetic Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetic Peripheral Neuropathy Treatment Revenue

3.4 Global Diabetic Peripheral Neuropathy Treatment Market Concentration Ratio

3.4.1 Global Diabetic Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Peripheral Neuropathy Treatment Revenue in 2023

3.5 Diabetic Peripheral Neuropathy Treatment Key Players Head office and Area Served

3.6 Key Players Diabetic Peripheral Neuropathy Treatment Product Solution and Service

3.7 Date of Enter into Diabetic Peripheral Neuropathy Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Peripheral Neuropathy Treatment Breakdown Data by Type

4.1 Global Diabetic Peripheral Neuropathy Treatment Historic Market Size by Type (2019-2024)

4.2 Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Type (2025-2030)

5 Diabetic Peripheral Neuropathy Treatment Breakdown Data by Application

5.1 Global Diabetic Peripheral Neuropathy Treatment Historic Market Size by Application (2019-2024)

5.2 Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diabetic Peripheral Neuropathy Treatment Market Size (2019-2030)

6.2 North America Diabetic Peripheral Neuropathy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024)

6.4 North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetic Peripheral Neuropathy Treatment Market Size (2019-2030)

7.2 Europe Diabetic Peripheral Neuropathy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024)

7.4 Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size (2019-2030)

8.2 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetic Peripheral Neuropathy Treatment Market Size (2019-2030)

9.2 Latin America Diabetic Peripheral Neuropathy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024)

9.4 Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size (2019-2030)

10.2 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Achelios Therapeutics Inc

11.1.1 Achelios Therapeutics Inc Company Detail

11.1.2 Achelios Therapeutics Inc Business Overview

11.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Introduction

11.1.4 Achelios Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.1.5 Achelios Therapeutics Inc Recent Development

11.2 Celgene Corp

11.2.1 Celgene Corp Company Detail

11.2.2 Celgene Corp Business Overview

11.2.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Introduction

11.2.4 Celgene Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.2.5 Celgene Corp Recent Development

11.3 Commence Bio Inc

11.3.1 Commence Bio Inc Company Detail

11.3.2 Commence Bio Inc Business Overview

11.3.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Introduction

11.3.4 Commence Bio Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.3.5 Commence Bio Inc Recent Development

11.4 Grunenthal GmbH

11.4.1 Grunenthal GmbH Company Detail

11.4.2 Grunenthal GmbH Business Overview

11.4.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Introduction

11.4.4 Grunenthal GmbH Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.4.5 Grunenthal GmbH Recent Development

11.5 Immune Pharmaceuticals Inc

11.5.1 Immune Pharmaceuticals Inc Company Detail

11.5.2 Immune Pharmaceuticals Inc Business Overview

11.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Introduction

11.5.4 Immune Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.5.5 Immune Pharmaceuticals Inc Recent Development

11.6 KPI Therapeutics Inc

11.6.1 KPI Therapeutics Inc Company Detail

11.6.2 KPI Therapeutics Inc Business Overview

11.6.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Introduction

11.6.4 KPI Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.6.5 KPI Therapeutics Inc Recent Development

11.7 Medifron DBT Co Ltd

11.7.1 Medifron DBT Co Ltd Company Detail

11.7.2 Medifron DBT Co Ltd Business Overview

11.7.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Introduction

11.7.4 Medifron DBT Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.7.5 Medifron DBT Co Ltd Recent Development

11.8 Mitsubishi Tanabe Pharma Corp

11.8.1 Mitsubishi Tanabe Pharma Corp Company Detail

11.8.2 Mitsubishi Tanabe Pharma Corp Business Overview

11.8.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Introduction

11.8.4 Mitsubishi Tanabe Pharma Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.8.5 Mitsubishi Tanabe Pharma Corp Recent Development

11.9 Novaremed Ltd

11.9.1 Novaremed Ltd Company Detail

11.9.2 Novaremed Ltd Business Overview

11.9.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Introduction

11.9.4 Novaremed Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.9.5 Novaremed Ltd Recent Development

11.10 Reata Pharmaceuticals Inc

11.10.1 Reata Pharmaceuticals Inc Company Detail

11.10.2 Reata Pharmaceuticals Inc Business Overview

11.10.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Introduction

11.10.4 Reata Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.10.5 Reata Pharmaceuticals Inc Recent Development

11.11 Relief Therapeutics Holding AG

11.11.1 Relief Therapeutics Holding AG Company Detail

11.11.2 Relief Therapeutics Holding AG Business Overview

11.11.3 Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Introduction

11.11.4 Relief Therapeutics Holding AG Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.11.5 Relief Therapeutics Holding AG Recent Development

11.12 ViroMed Co Ltd

11.12.1 ViroMed Co Ltd Company Detail

11.12.2 ViroMed Co Ltd Business Overview

11.12.3 ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Introduction

11.12.4 ViroMed Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

11.12.5 ViroMed Co Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Achelios Therapeutics Inc

Celgene Corp

Commence Bio Inc

Grunenthal

Immune Pharmaceuticals Inc

KPI Therapeutics Inc

Medifron DBT Co Ltd

Mitsubishi Tanabe Pharma Corp

Novaremed

Reata Pharmaceuticals Inc

Relief Therapeutics Holding AG

ViroMed

List of Tables

Table 1. Global Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antimunocel

Table 3. Key Players of ASP-8477

Table 4. Key Players of BNV-222

Table 5. Key Players of Capsaicin

Table 6. Key Players of CBX-129801

Table 7. Key Players of Others

Table 8. Global Diabetic Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Diabetic Peripheral Neuropathy Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Diabetic Peripheral Neuropathy Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Diabetic Peripheral Neuropathy Treatment Market Share by Region (2019-2024)

Table 12. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Diabetic Peripheral Neuropathy Treatment Market Share by Region (2025-2030)

Table 14. Diabetic Peripheral Neuropathy Treatment Market Trends

Table 15. Diabetic Peripheral Neuropathy Treatment Market Drivers

Table 16. Diabetic Peripheral Neuropathy Treatment Market Challenges

Table 17. Diabetic Peripheral Neuropathy Treatment Market Restraints

Table 18. Global Diabetic Peripheral Neuropathy Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Diabetic Peripheral Neuropathy Treatment Market Share by Players (2019-2024)

Table 20. Global Top Diabetic Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Peripheral Neuropathy Treatment as of 2023)

Table 21. Ranking of Global Top Diabetic Peripheral Neuropathy Treatment Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Diabetic Peripheral Neuropathy Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Diabetic Peripheral Neuropathy Treatment Product Solution and Service

Table 25. Date of Enter into Diabetic Peripheral Neuropathy Treatment Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Diabetic Peripheral Neuropathy Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2019-2024)

Table 29. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2025-2030)

Table 31. Global Diabetic Peripheral Neuropathy Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application (2019-2024)

Table 33. Global Diabetic Peripheral Neuropathy Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application (2025-2030)

Table 35. North America Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 50. Achelios Therapeutics Inc Company Detail

Table 51. Achelios Therapeutics Inc Business Overview

Table 52. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product

Table 53. Achelios Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 54. Achelios Therapeutics Inc Recent Development

Table 55. Celgene Corp Company Detail

Table 56. Celgene Corp Business Overview

Table 57. Celgene Corp Diabetic Peripheral Neuropathy Treatment Product

Table 58. Celgene Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 59. Celgene Corp Recent Development

Table 60. Commence Bio Inc Company Detail

Table 61. Commence Bio Inc Business Overview

Table 62. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Product

Table 63. Commence Bio Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 64. Commence Bio Inc Recent Development

Table 65. Grunenthal GmbH Company Detail

Table 66. Grunenthal GmbH Business Overview

Table 67. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Product

Table 68. Grunenthal GmbH Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 69. Grunenthal GmbH Recent Development

Table 70. Immune Pharmaceuticals Inc Company Detail

Table 71. Immune Pharmaceuticals Inc Business Overview

Table 72. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product

Table 73. Immune Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 74. Immune Pharmaceuticals Inc Recent Development

Table 75. KPI Therapeutics Inc Company Detail

Table 76. KPI Therapeutics Inc Business Overview

Table 77. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product

Table 78. KPI Therapeutics Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 79. KPI Therapeutics Inc Recent Development

Table 80. Medifron DBT Co Ltd Company Detail

Table 81. Medifron DBT Co Ltd Business Overview

Table 82. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Product

Table 83. Medifron DBT Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 84. Medifron DBT Co Ltd Recent Development

Table 85. Mitsubishi Tanabe Pharma Corp Company Detail

Table 86. Mitsubishi Tanabe Pharma Corp Business Overview

Table 87. Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Product

Table 88. Mitsubishi Tanabe Pharma Corp Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 89. Mitsubishi Tanabe Pharma Corp Recent Development

Table 90. Novaremed Ltd Company Detail

Table 91. Novaremed Ltd Business Overview

Table 92. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Product

Table 93. Novaremed Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 94. Novaremed Ltd Recent Development

Table 95. Reata Pharmaceuticals Inc Company Detail

Table 96. Reata Pharmaceuticals Inc Business Overview

Table 97. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product

Table 98. Reata Pharmaceuticals Inc Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 99. Reata Pharmaceuticals Inc Recent Development

Table 100. Relief Therapeutics Holding AG Company Detail

Table 101. Relief Therapeutics Holding AG Business Overview

Table 102. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Product

Table 103. Relief Therapeutics Holding AG Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 104. Relief Therapeutics Holding AG Recent Development

Table 105. ViroMed Co Ltd Company Detail

Table 106. ViroMed Co Ltd Business Overview

Table 107. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Product

Table 108. ViroMed Co Ltd Revenue in Diabetic Peripheral Neuropathy Treatment Business (2019-2024) & (US$ Million)

Table 109. ViroMed Co Ltd Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diabetic Peripheral Neuropathy Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Diabetic Peripheral Neuropathy Treatment Market Share by Type: 2023 VS 2030

Figure 3. Antimunocel Features

Figure 4. ASP-8477 Features

Figure 5. BNV-222 Features

Figure 6. Capsaicin Features

Figure 7. CBX-129801 Features

Figure 8. Others Features

Figure 9. Global Diabetic Peripheral Neuropathy Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Diabetic Peripheral Neuropathy Treatment Market Share by Application: 2023 VS 2030

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Others Case Studies

Figure 14. Diabetic Peripheral Neuropathy Treatment Report Years Considered

Figure 15. Global Diabetic Peripheral Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Diabetic Peripheral Neuropathy Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Diabetic Peripheral Neuropathy Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Diabetic Peripheral Neuropathy Treatment Market Share by Players in 2023

Figure 19. Global Top Diabetic Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Peripheral Neuropathy Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Diabetic Peripheral Neuropathy Treatment Revenue in 2023

Figure 21. North America Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Diabetic Peripheral Neuropathy Treatment Market Share by Country (2019-2030)

Figure 23. United States Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Diabetic Peripheral Neuropathy Treatment Market Share by Country (2019-2030)

Figure 27. Germany Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Market Share by Region (2019-2030)

Figure 35. China Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Diabetic Peripheral Neuropathy Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Diabetic Peripheral Neuropathy Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Diabetic Peripheral Neuropathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Achelios Therapeutics Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 50. Celgene Corp Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 51. Commence Bio Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 52. Grunenthal GmbH Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 53. Immune Pharmaceuticals Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 54. KPI Therapeutics Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 55. Medifron DBT Co Ltd Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 56. Mitsubishi Tanabe Pharma Corp Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 57. Novaremed Ltd Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 58. Reata Pharmaceuticals Inc Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 59. Relief Therapeutics Holding AG Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 60. ViroMed Co Ltd Revenue Growth Rate in Diabetic Peripheral Neuropathy Treatment Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neurologic Disorder Treatment Drug Market Research Report 2024

Diabetic Peripheral Neuropathy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetic Therapeutic Drugs Market Research Report 2025

Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Inflammatory Demyelinating Polyneuropathy Drug Market Research Report 2025

Global Type 2 Diabetes Therapeutics Market Research Report 2025

Nerve Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adrenomyeloneuropathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ischemic Optic Neuropathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetic Neuropathy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Anti Diabetes Drugs Market Research Report 2025

Neurology Digital Therapeutics Market

Global Diabetic Neuropathy Drugs Market Research Report 2024

Glycemic Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions